• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-K/A filed by Marchex Inc. (Amendment)

    4/29/24 5:22:42 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology
    Get the next $MCHX alert in real time by email
    10-K/A
    FY--12-31true000122413300012241332023-01-012023-12-310001224133us-gaap:CommonClassBMember2024-04-2500012241332023-06-300001224133us-gaap:CommonClassAMember2024-04-25xbrli:sharesiso4217:USD

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 10-K/A

    (Amendment No. 1)

     

    (Mark One)

    ☒

    ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the fiscal year ended December 31, 2023

    OR

    ☐

    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO

    For the transition period from to .

    Commission File Number 000-50658

     

    Marchex, Inc.

    (Exact name of Registrant as specified in its Charter)

     

    Delaware

     

    35-2194038

    (State or other jurisdiction of

    incorporation or organization)

    1200 5th Ave., Suite 1300,

    Seattle, Washington

    (Address of principal executive offices)

     

    (I.R.S Employer

    Identification No.)

     

    98101

    (Zip Code)

    Registrant’s telephone number, including area code: (206) 331-3300

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading Symbol(s)

     

    Name of each exchange on which registered

    Class B Common Stock, $0.01 par value per share

     

    MCHX

     

    The NASDAQ Stock Market LLC

    (NASDAQ Global Select Market)

    Securities registered pursuant to Section 12(g) of the Act: None

    Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

    Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

    Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

    Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer

    ☐

    Accelerated filer

    ☐

    Non-accelerated filer

    ☒

    Smaller reporting company

    ☒

    Emerging growth company

     

    ☐

     

     

     

    If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

    If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

    Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

    Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

    The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant, based on the closing price of the shares of Class B common stock on The NASDAQ Stock Market on June 30, 2023 was $73,935,229.

    The number of shares of Registrant’s Class A common stock outstanding as of April 25, 2024 was 4,660,927. The number of shares of Registrant’s Class B common stock outstanding as of April 25, 2024 was 39,017,668.

     

     


    Table of Contents

     

    DOCUMENTS INCORPORATED BY REFERENCE

     

    The following documents (or parts thereof) are incorporated by reference into the following parts of this Form 10-K/A: None.

     

     


     

    EXPLANATORY NOTE

    Marchex, Inc. (the “Company,” “we,” “us,” “our,” or “Marchex”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to amend our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”), as originally filed with the United States Securities and Exchange Commission (the “SEC”) on April 1, 2024. The purpose of this Amendment is to include Part III information which was to be incorporated by reference from our definitive proxy statement for our 2024 Annual Meeting of Stockholders. This information was previously omitted from the 10-K in reliance on General Instruction G(3) to Form 10-K, which permits the Part III information to be incorporated in our Form 10-K by reference from our definitive proxy statement if such statement is filed no later than 120 days after our fiscal year-end. We are filing this Amendment to include Part III information in our Form 10-K because a definitive proxy statement containing such information will not be filed by the Company within 120 days after the end of the fiscal year covered by our Form 10-K. The reference on the cover to the Form 10-K to the incorporation by reference to portions of our definitive proxy statement into Part III of the Form 10-K is hereby deleted. This Amendment also corrects an inadvertent error in the aggregate market value of the voting and non-voting common equity held by non-affiliates of the Company on June 30, 2023 set forth on the cover of the Form 10-K.

    In accordance with Rule 12b-15 under the United States Securities Exchange Act of 1934, as amended (the “Exchange Act”), the cover page to the Form 10-K, Part III, Items 10 through 14 of our Form 10-K are hereby amended and restated in their entirety. In addition, a new certification of our principal executive officer and principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 is attached dated as of the filing date of this Amendment. This Amendment does not amend or otherwise update any other information in our 10-K. Accordingly, this Amendment should be read in conjunction with our Form 10-K and with our filings with the SEC subsequent to our Form 10-K.

     

     


     

    TABLE OF CONTENTS

    Page

     

     

    Part III

    ITEM 10.

    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

    1

    ITEM 11.

    EXECUTIVE COMPENSATION

    3

    ITEM 12.

    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

    14

    ITEM 13.

    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

    17

    ITEM 14.

    PRINCIPAL ACCOUNTING FEES AND SERVICES

    18

    Part IV

    ITEM 15.

    EXHIBITS, FINANCIAL STATEMENT SCHEDULES

    19

    In Marchex’s filings with the SEC, information is sometimes "incorporated by reference." This means that we refer you to information previously filed with the SEC that should be considered as part of the particular filing. In addition, this Amendment includes a website address. This website address is intended to provide inactive, textual references only. The information on this website is not part of this Amendment.

     


    Table of Contents

     

    PART III

    ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

    Directors

     

    The Board of Directors currently consists of five (5) individuals. Directors are elected to hold office until the next annual meeting of stockholders and until their respective successors have been elected and qualified. The names and the respective ages of our directors are set forth below:

     

    Name

    Age

    Position

    Director Since

    Mike Arends

    54

    Vice Chairman

    February 2023

    Dennis Cline (1)(2)(3)

    63

    Director

    May 2003

    Donald Cogsville (1)(2)(3)

    58

    Director

    April 2019

    Russell C. Horowitz

    57

    Chairman

    August 2017

    M. Wayne Wisehart (1)(2)(3)

    78

    Director

    November 2008

     

    1.
    Member of the Audit Committee.
    2.
    Member of the Nominating and Governance Committee.
    3.
    Member of the Compensation Committee

     

    Set forth below is a description of the business experience of each current director, including a discussion of the specific experience, qualifications, attributes and skills that led our Board of Directors to conclude that those individuals should serve as our directors.

     

    Michael Arends. Mr. Arends has served as our Vice Chairman since February 2023. Mr. Arends served as our Co-CEO, including previously as a member of the Office of the CEO from October 2016 to February 2023, and served as our Chief Financial Officer from May 2003 through April 2021. Prior to joining Marchex, Mr. Arends held various positions at KPMG since 1992, most recently as a Partner in KPMG’s Pacific Northwest Information, Communications and Entertainment assurance practice. Mr. Arends is a Certified Public Accountant and a Chartered Accountant and received a Bachelor of Commerce degree from the University of Alberta. Mr. Arends brings historic knowledge and continuity together with extensive operational, finance, accounting, and transactional experience to the board.

     

    Dennis Cline. Mr. Cline has served as a member of our Board of Directors since May 2003. Previously, Mr. Cline served on the board of advisors of Blackstratus, a provider of security information event management products and services from 2014 through 2019. Mr. Cline served on the board of directors of TraceSecurity, a provider of cloud-based security solutions, from 2003 to 2015. From 2004 to 2006, Mr. Cline served as Chief Executive Officer and Executive Chairman of netForensics, a provider of security event information management. Prior to joining netForensics as its Chief Executive Officer, Mr. Cline was Managing Partner of DMC Investments, a firm he founded in 2000, which provides capital and consulting services to technology companies. From 1988 to 2000, Mr. Cline was the CEO of DirectWeb, a provider of computer hardware and Internet access for consumers. Prior to DirectWeb, Mr. Cline was a senior executive at Network Associates, a provider of computer security solutions. Mr. Cline received his J.D. from Rutgers School of Law and his B.A. from Rutgers University. Mr. Cline brings extensive governance, marketing, sales and broad management expertise to the board.

     

    Donald Cogsville. Mr. Cogsville has served as a member of our Board of Directors since April 2019. Mr. Cogsville is the Chief Executive Officer of The Cogsville Group, LLC, a New York-based, private equity real estate investment firm founded in 2007. Mr. Cogsville began his career as an attorney in the Structured Finance Group at Skadden, Arps, Slate, Meagher & Flom LLP. Subsequently, Mr. Cogsville joined the Leveraged Finance Group at Merrill Lynch as an investment banker. Additionally, Mr. Cogsville serves or has served on the Board of Visitors of University of North Carolina, The New York Urban League, Jazz at Lincoln Center, The Amsterdam News Editorial Board and founded the non-partisan voter registration initiative, Citizen Change. Mr. Cogsville

    1


    Table of Contents

     

    received his J.D. from Rutgers School of Law and his B.A. from University of North Carolina at Chapel Hill. Mr. Cogsville brings extensive operational, finance and transactional experience to the board.

     

    Russell C. Horowitz. Mr. Horowitz is a founder of our Company and has served as our Chairman since April 2019. Mr. Horowitz served as our Co-CEO, including previously as a member of the Office of the CEO from October 2016 to February 2023. Previously, Mr. Horowitz served as our Executive Director since August 2017. Immediately prior, Mr. Horowitz, served as a consultant to the Company from May of 2016 through August 2017. Prior to serving as a consultant to the Company, Mr. Horowitz served as Executive Director from February 2015 to May 2016 and as CEO, Treasurer and Chairman of the Board from inception to February 2015. Mr. Horowitz was previously a founder of Go2Net, a provider of online services to merchants and consumers, including merchant Web hosting, online payment authorization technology, and Web search and directory services. He served as its Chairman and Chief Executive Officer from its inception in February 1996 until its merger with InfoSpace in October 2000, at which time Mr. Horowitz served as the Vice Chairman and President of the combined company through the merger integration process. Additionally, Mr. Horowitz served as the Chief Financial Officer of Go2Net from its inception until May 2000. Prior to Go2Net, Mr. Horowitz served as the Chief Executive Officer and a director of Xanthus Management, LLC, the general partner of Xanthus Capital, a merchant bank focused on investments in early-stage companies, and was a founder and Chief Financial Officer of Active Apparel Group, now Everlast Worldwide. Mr. Horowitz received a B.A. in Economics from Columbia College of Columbia University. Mr. Horowitz brings historic knowledge and continuity together with extensive operational and industry expertise to the board.

     

    M. Wayne Wisehart. Mr. Wisehart has served as a member of our Board of Directors since November 2008. From February 2010 to November 2010, Mr. Wisehart served as Chief Financial Officer for All Star Directories, a publisher of online and career school directories. Mr. Wisehart previously served as the Chief Financial Officer of aQuantive, Inc. (formerly Avenue A Media, Inc.), a leading global digital marketing company, which was acquired by Microsoft in August 2007. Prior to aQuantive, Mr. Wisehart served as Chief Financial Officer of Western Wireless Corporation, a cellular phone service provider, which was acquired by Alltel in August 2005. Mr. Wisehart also served as the Chief Financial Officer from 2000 to 2002 of iNNERHOST, Inc., a Web hosting services company, as President and Chief Executive Officer from 1999 to 2000 of TeleDirect International Inc., a company that provides customer interaction systems, and as the President and Chief Executive Officer from 1997 to 1998 of Price Communications Wireless. Mr. Wisehart received a B.S. degree in Business from the University of Missouri-St. Louis. Mr. Wisehart brings extensive financial and accounting expertise to the board.

     

    Executive Officers

     

    Our current executive officers, their positions with the Company and their respective ages, are as follows:

     

    Name

    Age

    Position

    Edwin Miller

    54

    CEO

    Troy Hartless

    53

    Chief Revenue Officer

    Holly Aglio

    47

    Chief Financial Officer

     

    Biographical information for our executive officers is set forth below.

     

    Edwin Miller. Mr. Miller has served as our CEO since February 2023. Prior to joining Marchex, Mr. Miller served as an Operating Executive with Gemspring Capital since May 2021, as President, CEO and Director of The Interest Group from January through December 2020, and as President, CEO and Director of Astreya Partners from 2014 to 2019. Mr. Miller received a Bachelor of Science, Management degree from Liberty University - Dual Minors (German and French), and a MBA in Business, Finance, and International Affairs from The George Washington University School of Business.

     

    Troy Hartless. Mr. Hartless has served as our Chief Revenue Officer since April 2023. Prior to joining Marchex, Mr. Hartless was the Chief Executive Officer of TLJ Capital since 2009. Prior to TLJ Capital, Mr. Hartless was the Chief Operating Officer of Govplace, Inc. from 2019 to 2020 and the Chief Revenue Officer of

    2


    Table of Contents

     

    9Lenses from 2017 to 2019. Mr. Hartless received a Bachelor of Science, Business Administration degree from Liberty University.

     

    Holly Aglio. Ms. Aglio has served as our Chief Financial Officer since October 2023. Prior to joining Marchex, Ms. Aglio previously served as Chief Financial Officer of NetCentrics Corporation since 2021, as Chief Financial Officer of Govplace, Inc. from 2019 to 2021 and previously as Director, Finance and Accounting from 2017 to 2019 and as Corporate Controller from 2014 to 2017, as Corporate Controller of Artel, LLC from 2012 to 2014, and as Senior Director of Accounting and Assistant Controller of Apptis, Inc. from 2010 to 2012. Prior to joining Apptis, Ms. Aglio held several positions at PriceWaterhouseCoopers, LLP from 1998 to 2010, most recently as Senior Manager, Audit. Ms. Aglio is a Certified Public Accountant and received a Bachelor of Science in Commerce degree from the University of Virginia.

     

    Corporate Governance

     

    Section 16(a) Beneficial Ownership Reporting Compliance. Section 16(a) of the Securities Exchange Act of 1934 requires the Company’s directors, officers and persons who beneficially own more than 10% of a registered class of the Company’s equity securities to file with the SEC initial reports of ownership and reports of changes in ownership. Directors, officers and 10% stockholders are required by SEC regulations to furnish the Company with copies of all Section 16(a) reports they file. Based solely on review of the copies of such reports the Company has received, or written representations that no other reports were required for those persons, the Company believes that its directors, officers and 10% stockholders complied with all applicable filing requirements during 2023.

     

    Code of Conduct and Code of Ethics. The Company has adopted a code of conduct applicable to each of the Company’s officers, directors and employees, and a code of ethics applicable to the Company’s Chief Executive Officer, Chief Financial Officer and the Company’s senior financial officers, as contemplated by Section 406 of the Sarbanes-Oxley Act of 2002 and both codes are available on our website at www.marchex.com.

     

    Audit Committee. The Audit Committee is currently comprised of Messrs. Cline, Cogsville and Wisehart (Chair). Each of the members of the Audit Committee is independent for purposes of the NASDAQ listing standards as they apply to Audit Committee members and each member of the Audit Committee is an Audit Committee financial expert, as defined in the rules of the Securities and Exchange Commission. The Audit Committee operates under a charter that is available on our website at www.marchex.com. The functions of the Audit Committee include reviewing, with the Company’s independent registered public accounting firm, the scope and timing of the independent registered public accounting firm’s services, the independent registered public accounting firm’s report on the Company’s consolidated financial statements and internal control over financial reporting following completion of the Company’s audits, and the Company’s internal accounting and financial control policies and procedures, and making annual recommendations to the Board of Directors for the appointment of an independent registered public accounting firm for the ensuing year. The Audit Committee held eight meetings and took action by written consent on one occasion during the fiscal year ended December 31, 2023.

    ITEM 11. EXECUTIVE COMPENSATION.

    Compensation Discussion and Analysis

     

    The Role of Stockholder Say-on-Pay Votes

     

    In September 2023, we held a stockholder advisory vote to approve the compensation of our named executive officers (the “say-on-pay proposal”). Our stockholders overwhelmingly approved the compensation of our named executive officers, with approximately 95% of stockholder votes cast in favor of the say-on-pay proposal. The Compensation Committee believes this affirms the stockholders’ support of our approach to executive compensation and did not change its approach in 2023.

     

    The Compensation Committee will continue to consider the outcome of our say-on-pay votes when making future compensation decisions for the named executive officers.

    3


    Table of Contents

     

     

    Overview

     

    You can find detailed information regarding the compensation we paid to our NEOs in the table following the Summary Compensation Table section of this Amendment below.

     

    Our executive compensation programs are intended to serve two related goals:

    •
    Long-Term Retention of our Strong Management Team. We believe that our continued success depends on our ability to retain our experienced, complementary and dedicated management team. Although we always consider the ultimate interest of our stockholders in setting NEO compensation, we also must acknowledge that our executives face many career options and we therefore must provide strong incentives for them to continue to participate in our growth.
    •
    Long-Term Growth in Stockholder Value. We believe that management compensation packages should reflect as much as possible the risk and opportunity experienced by our stockholders. As a result, we strongly emphasize performance-based compensation arrangements which reward NEOs for contributions to our long-term growth and overall corporate success.

    We believe that this long-term focus will appropriately reward our management team for performance that will most benefit our Company and stockholders. We think that a focus on shorter-term results could inappropriately over- or under-compensate our executives due to short-term fluctuations that do not as accurately reflect our corporate growth and the corresponding benefit to our stockholders.

     

    The Compensation Committee is responsible for setting the compensation and benefits for our executive officers, for determining distributions and grants of awards under our various stock and other incentive plans, and for all matters related to the foregoing.

     

    NEO Compensation for 2023

     

    Our Compensation Committee in reviewing our executive compensation packages assesses salary and bonus, salary and bonus history, the number and value of shares owned by our executives, and vesting and exercise history of prior equity grants. The Compensation Committee also considers data regarding compensation paid at public media, internet and technology-based companies of comparable size to our Company and which could compete for the services of our NEOs. Although the compensation practices of our competitors instruct our review, we use that data only to gain perspective and do not “benchmark” our compensation to any particular level.

    Base Salary and Bonus

     

    The 2023 salaries and bonuses shown in the table following the Summary Compensation Table section of this Amendment below were set by our Compensation Committee based on the compensation review discussed above, as well as a consideration of the respective NEO’s total compensation package including prior equity grants, exercise history, and existing stock ownership. Base salaries and bonuses are a necessary part of our compensation program and provide executives with a fixed portion of pay that is not performance-based. Our goal is to provide competitive base pay levels. The Compensation Committee considered each NEO’s skills, experience, level of responsibility, performance and contribution to our Company. The Compensation Committee also took into account in conjunction with the NEO’s specific areas of responsibilities and objectives, each NEO’s contribution to the Company’s overall success as a member of the management team. The Compensation Committee considers the relative compensation levels among all the members of the management team to ensure the Company’s executive compensation programs are internally consistent and equitable. All salaries and bonuses are reviewed at least annually and subject to future adjustment by the Compensation Committee.

     

    Equity Compensation

     

    4


    Table of Contents

     

    All of our employees and directors are eligible to receive options, shares of restricted stock, and/or restricted stock units under our 2021 Stock Incentive Plan (the “2021 Stock Plan”).

     

    The Compensation Committee periodically and at least annually considers equity awards to the Company's NEOs, but does not automatically grant equity awards to NEOs every year. The Compensation Committee takes into account the various factors outlined in the discussion of base salary and bonus above as well as the Company’s financial performance and its impact on stockholder value and also analyzes existing NEO equity holdings and prior equity awards to take into account whether additional grants are appropriate and necessary to recalibrate the cash-equity balance of NEO compensation packages.

     

    On January 25, 2023, the Compensation Committee granted stock options and shares of restricted stock to Messrs. Arends, Horowitz, and Polley under the 2021 Stock Plan pursuant to a periodic review of equity award incentives for executive officers of the Corporation.

     

    On February 3, 2023, the Compensation Committee granted stock options to Mr. Miller under the 2021 Stock Plan in connection with his appointment as Chief Executive Officer of the Company.

     

    On April 3, 2023, the Compensation Committee granted stock options to Mr. Hartless under the 2021 Stock Plan in connection with his appointment as Chief Revenue Officer of the Company.

     

    On September 28, 2023, the Compensation Committee granted stock options to Messrs. Miller and Hartless under the 2021 Stock Plan pursuant to a periodic review of equity award incentives for executive officers of the Corporation.

     

    On October 30, 2023, the Compensation Committee granted stock options to Ms. Aglio under the 2021 Stock Plan in connection with her appointment as Chief Financial Officer of the Company.

     

    You can find more information regarding these grants, including the corresponding vesting schedules, by referring to the table following the Outstanding Equity Awards at 2023 Fiscal Year-End section of this Amendment below.

     

    Most equity awards for employees are tied to their annual performance reviews. We may occasionally make employee grants outside of that review process and such awards typically are granted as of the date the grant is approved. All new-hire awards have a grant date set to correspond to the date of hire. All options have an exercise price set at the closing market price of our Class B common stock on the grant date.

     

    Risk Assessment of Compensation Policies and Practices

     

    We believe our compensation policies and practices do not promote imprudent risk taking. In this regard, we note the following: (i) our annual incentive compensation is based on balanced performance metrics that promote disciplined progress towards longer-term Company goals; (ii) we do not offer short-term incentives that might drive high-risk investments at the expense of long-term Company value; and (iii) our compensation programs are weighted towards offering long-term incentives that reward sustainable performance, especially when considering our executive share ownership. Accordingly, we believe that our compensation policies and practices do not create risks that are reasonably likely to have a material adverse effect on the Company.

     

    Compensation Committee Interlocks and Insider Participation

     

    None of the members of the Compensation Committee during 2023, are or have been an officer or employee of the Company. No member of the Compensation Committee had any relationship with the Company requiring disclosure under Item 404 of Regulation S-K. During fiscal year 2023, none of the Company’s executive officers served on the Compensation Committee (or its equivalent) or Board of Directors of another entity where any of that entity's executive officers also served on the Company’s Compensation Committee or Board of Directors.

    5


    Table of Contents

     

    Summary Compensation Table (1)

     

    The following table sets forth information concerning the compensation earned during the fiscal years ended December 31, 2022 and 2023, as applicable, by our NEOs:

     

     Name and Principal Position

    Year

    Salary ($)

    Bonus ($)

    Stock Awards (2) ($)

    Option Awards (3) ($)

    Non-equity Compensation ($)

    All Other Compensation (4) ($)

    Total ($)

    Edwin Miller

    2023

    386,363

    -

    -

    1,073,750

    -

    -

    1,460,113

    CEO

    2022

    -

    -

    -

    -

    -

    -

    -

    Troy Hartless

    2023

    281,250

    -

    -

    600,500

    -

    -

    881,750

    Chief Revenue Officer

    2022

    -

    -

    -

    -

    -

    -

    -

    Holly Aglio

    2023

    57,292

    50,000

    -

    237,000

    -

    -

    344,292

    Chief Financial Officer

    2022

    -

    -

    -

    -

    -

    -

    -

    Mike Arends (5)

    2023

    297,500

    -

    139,750

    81,900

    -

    11,466

    530,616

    Vice Chairman

    2022

    297,500

    -

    387,360

    204,000

    279,836

    12,353

    1,181,049

    Russell C. Horowitz (6)

    2023

    319,161

    -

    123,750

    94,517

    -

    -

    537,428

    Chairman

    2022

    255,000

    -

    271,080

    145,390

    217,547

    -

    889,017

    Ryan Polley

    2023

    286,905

    61,111

    278,600

    55,000

    -

    -

    681,616

    Former President and Chief Operating Officer

    2022

    350,000

    172,779

    127,500

    60,500

    -

    -

    710,779

    John Roswech

    2023

    53,255

    45,139

    -

    -

    -

    15,000

    113,394

    Former Chief Revenue Officer

    2022

    400,000

    214,733

    127,500

    60,500

    -

    -

    802,733

     

    (1)
    Includes only those columns relating to compensation awarded to, earned by or paid to the NEOs in 2022 and 2023.
    (2)
    These amounts do not reflect whether the NEO has actually realized or will realize a financial benefit from the awards (such as by vesting of a stock award). Amounts represent the aggregate grant date fair value of stock awards each year computed in accordance with ASC 718, excluding the effect of forfeitures. For a more detailed discussion on the valuation model and assumptions used to calculate the fair value of each stock award, refer to Note 6 to the Consolidated Financial Statements contained in our 2023 Annual Report on Form 10-K filed on April 1, 2024.
    (3)
    These amounts do not reflect whether the NEO has actually realized or will realize a financial benefit from the awards (such as by exercising stock options). Amounts represent the aggregate grant date fair value of option awards each year computed in accordance with ASC 718, excluding the effect of forfeitures. The fair value of the shares underlying the option awards that vest based on time is estimated using the Black-Scholes option pricing model. For a more detailed discussion on the valuation model and assumptions used to calculate the fair value of each stock award, refer to Note 6 to the Consolidated Financial Statements contained in our 2023 Annual Report on Form 10-K filed on April 1, 2024.
    (4)
    Unless otherwise noted, the total of all perquisites and personal benefits of each NEO falls below the reportable amount for disclosure within this table. Mr. Arends’ amounts in 2022 and 2023 exceeded the reportable amount and includes the Company’s 401K matching contribution and auto allowance. Mr. Roswech's amount in 2023 exceeded the reportable amount and includes severance pay.
    (5)
    In September 2023, Mr. Arends received an annual director restricted stock grant of 15,000 shares under Marchex's 2021 Stock Incentive Plan, with fifty (50%) percent of such shares of restricted stock vesting on the first anniversary of the grant date, and with vesting in full in the event of a Change in Control.
    (6)
    In September 2022 and 2023, Mr. Horowitz received an annual director restricted stock grant of 15,000 shares under Marchex’s 2021 Stock Incentive Plan, with fifty (50%) percent of such shares of restricted stock vesting on the first annual anniversary of the grant date, and with vesting in full in the event of a Change in Control.

     

    Outstanding Equity Awards at 2023 Fiscal Year-End (1)

     

    The following table sets forth certain information with respect to the value of all unexercised options and unvested stock awards previously awarded to our NEOs as of December 31, 2023. Certain option and stock

    6


    Table of Contents

     

    awards provide for accelerated vesting, in certain circumstances. For more information on these acceleration provisions, please refer to section Potential Payments upon Termination or Change in Control at 2023 Fiscal Year-End of this Amendment below.

     

     

     

    Option Awards

     

    Stock Awards

     Name

    Grant Date

    Number of
    Securities
    Underlying
    Unexercised
    Options
    Exercisable
    (#)

    Number of
    Securities
    Underlying
    Unexercised
    Options
    Unexercisable (#)

    Option
    Exercise
    Price
    ($)

    Option
    Expiration
    Date

     

    Number of
    Shares or
    Units of Stock
    That Have Not
    Vested
    (#)

    Market Value of
    Shares or Units of
    Stock That Have
    Not Vested
    (2)
    ($)

    Edwin Miller

     

    Stock Options

    2/3/2023 (5)

    —

    300,000

    2.09

    2/3/2033

     

    —

    —

    Stock Options

    2/3/2023 (8)

    —

    375,000

    2.09

    2/3/2033

     

    —

    —

    Stock Options

    9/28/2023 (5)

    —

    350,000

    1.45

    9/28/2033

     

    —

    —

    Troy Hartless

     

    Stock Options

    4/3/2023 (5)

    —

    150,000

    1.86

    4/3/2033

     

    —

    —

    Stock Options

    4/3/2023 (8)

    —

    200,000

    1.86

    4/3/2033

     

    —

    —

    Stock Options

    9/28/2023 (5)

    —

    300,000

    1.45

    9/28/2033

     

    —

    —

    Holly Aglio

     

    Stock Options

    10/30/2023 (5)

    —

    300,000

    1.38

    10/30/2033

     

    —

    —

    Michael Arends

     

    Stock Options

    12/31/2020 (9)

    195,000

    —

    1.96

    12/31/2030

     

    —

    —

    Stock Options

    1/4/2021 (5)

    31,625

    14,375

    2.02

    1/4/2031

     

    —

    —

    Restricted Stock

    1/4/2021 (3)

    —

    —

    —

    —

     

    23,000

    31,280

    Stock Options

    12/30/2021 (6)

    49,000

    49,000

    2.57

    12/30/2031

     

    —

    —

    Restricted Stock

    12/30/2021 (6)

    —

    —

    —

    —

     

    49,000

    66,640

    Stock Options

    1/3/2022 (5)

    25,813

    33,187

    2.56

    1/4/2032

     

    —

    —

    Restricted Stock

    1/3/2022 (3)

    —

    —

    —

    —

     

    44,250

    60,180

    Stock Options

    12/30/2022 (7)

    —

    149,000

    1.60

    12/30/2032

     

    —

    —

    Restricted Stock

    12/30/2022 (7)

    —

    —

    —

    —

     

    149,000

    202,640

    Stock Options

    1/25/2023 (5)

    —

    59,000

    2.00

    1/25/2033

     

    —

    —

    Restricted Stock

    1/25/2023 (3)

    —

    —

    —

    —

     

    59,000

    80,240

    Stock Options

    9/28/2023 (4)

    —

    20,000

    1.45

    9/28/2033

     

    —

    —

    Restricted Stock

    9/28/2023 (4)

    —

    —

    —

    —

     

    15,000

    20,400

    Russell C. Horowitz

     

    Stock Options

    12/31/2020 (9)

    195,000

    —

    1.96

    12/31/2030

     

    —

    —

    Stock Options

    1/4/2021 (5)

    28,188

    12,812

    2.02

    1/4/2031

     

    —

    —

    Restricted Stock

    1/4/2021 (3)

    —

    —

    —

    —

     

    20,500

    27,880

    Restricted Stock

    10/4/2021 (4)

    20,000

    —

    —

    —

     

    —

    —

    Stock Options

    12/30/2021 (6)

    23,750

    23,750

    2.57

    12/30/2031

     

    —

    —

    Restricted Stock

    12/30/2021 (6)

    —

    —

    —

    —

     

    23,750

    32,300

    Stock Options

    1/3/2022 (5)

    22,313

    28,687

    2.56

    1/4/2032

     

    —

    —

    Restricted Stock

    1/3/2022 (3)

    —

    —

    —

    —

     

    38,250

    52,020

    Stock Options

    9/29/2022 (4)

    10,000

    10,000

    1.78

    10/1/2032

     

    —

    —

    Restricted Stock

    9/29/2022 (4)

    —

    —

    —

    —

     

    7,500

    10,200

    Stock Options

    12/30/2022 (7)

    —

    72,000

    1.60

    12/30/2032

     

    —

    —

    Restricted Stock

    12/30/2022 (7)

    —

    —

    —

    —

     

    72,000

    97,920

    Stock Options

    1/25/2023 (5)

    —

    51,000

    2.00

    1/25/2033

     

    —

    —

    Restricted Stock

    1/25/2023 (3)

    —

    —

    —

    —

     

    51,000

    69,360

    Stock Options

    9/28/2023 (4)

    —

    20,000

    1.45

    9/28/2033

     

    —

    —

    Restricted Stock

    9/28/2023 (4)

    —

    —

    —

    —

     

    15,000

    20,400

     

    (1)
    Includes only those columns for which there are outstanding equity awards at December 31, 2023. All other columns have been omitted.
    (2)
    The market value of unvested stock awards is calculated by multiplying the number of unvested stock awards held by the applicable NEO by the closing price of $1.36 per share of our Class B common stock on the NASDAQ Global Select Market on December 31, 2023.
    (3)
    The shares of restricted stock vest at the rate of 25% on each of the first, second, third, and fourth anniversaries, respectively, of the grant date.
    (4)
    The director grant of option and shares of restricted stock vest 50% on the first and second anniversary of the grant date assuming continued service on Marchex's Board of Directors on the vesting date.

    7


    Table of Contents

     

    (5)
    The options vest over four years, with 25% of the option shares vesting on the first anniversary and vesting quarterly thereafter over the next three years.
    (6)
    The options and shares of restricted stock vest on the fifth annual anniversary of the grant date with accelerated vesting as follows: (a) 50% of such options and shares of restricted stock shall vest upon attainment of specified revenue, adjusted OIBA or share price targets at the later of eighteen (18) months or performance attainment (2022 revenue (or trailing 12 months revenue) exceeding 120% of 2021 level, 2022 adjusted OIBA (or trailing 12 months adjusted OIBA) exceeding specified multiples of 2021 level, or the Class B Common Stock share price for twenty (20) consecutive trading days exceeding 150% of the initial 2021 consecutive trading day average), and (b) such remaining unvested options and shares of restricted stock upon attainment of specified revenue, adjusted OIBA or share price targets at the later of thirty (30) months or performance attainment (trailing twelve (12) month revenue exceeding 127% of 2021 level, trailing twelve (12) month adjusted OIBA exceeding specified multiples of 2021 level higher than the initial performance target above, or the Class B Common Stock share price for twenty (20) consecutive trading days exceeding 160% of the initial 2021 consecutive trading day average.
    (7)
    The options and shares of restricted stock vest on the fifth annual anniversary of the grant date with accelerated vesting as follows: (a) 50% of such options and shares of restricted stock shall vest upon attainment of specified revenue, adjusted OIBA or share price targets at the later of eighteen (18) months or performance attainment (2023 revenue (or trailing 12 months revenue) exceeding 120% of 2022 level, 2023 adjusted OIBA (or trailing 12 months adjusted OIBA) exceeding specified multiples of 2022 level, or the Class B Common Stock share price for twenty (20) consecutive trading days exceeding 150% of the initial 2022 consecutive trading day average), and (b) such remaining unvested options and shares of restricted stock upon attainment of specified revenue, adjusted OIBA or share price targets at the later of thirty (30) months or performance attainment (trailing twelve (12) month revenue exceeding 127% of 2022 level, trailing twelve (12) month adjusted OIBA exceeding specified multiples of 2022 level higher than the initial performance target above, or the Class B Common Stock share price for twenty (20) consecutive trading days exceeding 160% of the initial 2022 consecutive trading day average.
    (8)
    The options vest on the fifth annual anniversary of the Start Date with accelerated vesting upon certain events and subject to continued employment at all such times. With respect to acceleration, (a) 50% of such option shares shall vest upon attainment of specified revenue, adjusted OIBA or share price targets at the later of twenty-four (24) months or performance attainment (2023 revenue (or subsequent years) exceeding 120% of year of grant level, 2023 adjusted OIBA (or subsequent years) exceeding specified multiples of year of grant level, or following the first year the Class B Common Stock share price for twenty (20) consecutive trading days exceeding 150% of the year of grant trading day average), and (b) such remaining unvested option shares shall vest upon attainment of specified revenue, adjusted OIBA or share price targets at the later of thirty-six (36) months or performance attainment (2023 revenue (or subsequent years) exceeding 127% of year of grant level, 2023 adjusted OIBA (or subsequent years) exceeding specified multiples of year of grant level higher than the initial performance target above, or following the first year the Class B Common Stock share price for twenty (20) consecutive trading days exceeding 160% of the year of grant trading day average.
    (9)
    The options and shares of restricted stock vest on the fifth annual anniversary of the grant date with accelerated vesting as follows: (a) 50% of such options and shares of restricted stock vest upon attainment of specified revenue, adjusted OIBA or share price targets at the later of eighteen (18) months or performance attainment (2021 revenue (or trailing twelve (12) months revenue) exceeding 120% of 2020 level, 2021 adjusted OIBA (or trailing twelve (12) months adjusted OIBA) exceeding specified multiples of 2020 level, or the Class B common stock share price for twenty (20) consecutive trading days exceeding 150% of the initial 2020 consecutive trading day average), and (b) such remaining unvested options and shares of restricted stock vest upon attainment of specified revenue, adjusted OIBA or share price targets at the later of thirty (30) months or performance attainment (trailing twelve (12) month revenue.

     

    Potential Payments upon Termination or Change in Control at 2023 Fiscal Year-End

     

    Employment Arrangements

     

    Pursuant to the terms of our employment arrangements with Mr. Miller, the stock options granted to him upon appointment as Chief Executive Officer of the Company will become vested and nonforfeitable following the occurrence of a “Change in Control” (as defined) of the Company as follows: 1/3rd upon occurrence of a Change in Control, 1/3rd upon the eighteen month anniversary, and 1/3rd upon the second annual anniversary, respectively, of such Change in Control. In the event that Miller is terminated by the Company without “Cause” (as defined) prior to the occurrence of a Change in Control, Miller will receive the following: (a) for termination before the one year anniversary of the his start date, a lump sum payment equal to one year of base salary plus any accrued bonus through the date of termination, and an additional twenty-five percent (25%) of vesting on such Options; (b) for

    8


    Table of Contents

     

    termination on or following the one year anniversary of his start date and before the two year anniversary of his start date, a lump sum payment equal to one year of base salary plus any earned bonus for the prior calendar year if not yet paid plus any accrued bonus through the date of termination, and an additional fifty percent (50%) of vesting on such Options; and (c) for termination on or following the two year anniversary of the his start date, a lump sum payment equal to one year of base salary plus any earned bonus for the prior calendar year if not yet paid plus any accrued bonus through the date of termination, and one hundred percent (100 %) of vesting on such Options. In the event that Miller is terminated by the Company without Cause upon or following the occurrence of a Change in Control, Miller will receive the following: (a) a lump sum payment equal to one year of base salary plus (i) any accrued bonus through the date of termination if before the one year anniversary of his start date, or (ii) any earned bonus for the prior year if not yet paid plus any accrued bonus through the date of termination if on or after the one year anniversary of his start date, and an additional fifty percent (50%) of vesting on such Options; and (b) upon the 18 month anniversary of the Change in Control, one hundred percent (100%) of vesting on such Options.

     

    Pursuant to the terms of our employment arrangements with Mr. Hartless, the stock options granted to him upon appointment as Chief Revenue Officer of the Company will become vested and nonforfeitable following the occurrence of a “Change in Control” (as defined) of the Company as follows: 25% upon occurrence of a Change in Control, 25% upon the eighteen month anniversary, and 50% upon the second annual anniversary, respectively, of such Change in Control. In the event that Hartless is terminated by the Company without “Cause” (as defined) more than three months prior to the occurrence of a Change in Control, Hartless will receive the following: (a) for termination before the one year anniversary of his start date, a lump sum payment equal to six months of base salary plus any accrued bonus through the date of termination, and an additional twenty-five percent (25%) of vesting on such Options; (b) for termination on or following the one year anniversary of his start date, a lump sum payment equal to nine months of base salary plus any earned bonus for the prior calendar year if not yet paid plus any accrued bonus through the date of termination, and an additional fifty percent (50%) of vesting on such Options. In the event that Hartless is terminated by the Company without Cause within three months prior to or upon or following the occurrence of a Change in Control, Hartless will receive the following: (a) a lump sum payment equal to nine months of base salary plus (i) any accrued bonus through the date of termination if before the one year anniversary of his start date, or (ii) any earned bonus for the prior year if not yet paid plus any accrued bonus through the date of termination if on or after the one year anniversary of his start date, and an additional fifty percent (50%) of vesting on such Options; and (b) upon the 18 month anniversary of the Change in Control, one hundred percent (100%) of vesting on such Options.

     

    Pursuant to the terms of our employment arrangements with Ms. Aglio, the stock options granted to her upon appointment as Chief Financial Officer of the Company will become vested in full and nonforfeitable upon the occurrence of a “Change in Control” (as defined). In the event that Aglio is terminated by the Company without “Cause” (as defined), Aglio will receive the following: (a) for termination before the one year anniversary of her start date, a lump sum payment equal to three months of base salary plus any accrued bonus through the date of termination, and an additional twenty-five percent (25%) of vesting on such Options; (b) for termination on or following the one year anniversary of her start date, a lump sum payment equal to six months of base salary plus any earned bonus for the prior calendar year if not yet paid plus any accrued bonus through the date of termination, and an additional fifty percent (50%) of vesting on such Options.

     

    The Amended and Restated Executive Officer Employment Agreement for Mr. Arends provides that in the event the Company terminates executive’s employment for any reason other than Cause, or executive terminates his employment for Good Reason (regardless of a Change in Control) and subject to executive’s execution of a release of claims, executive will be eligible to receive the following severance and related post-termination benefits: (a) a lump sum payment equal to one (1) times executive’s then annual salary payable at the time of termination, unless the termination of executive’s employment occurs within 12 months following a Change in Control, in which case executive will receive the benefits under his Retention Agreement, (b) payment by the Company of its share of medical, dental and vision insurance premiums under COBRA (“Health Benefits”) for executive and executive’s dependents for the 12 month period following the termination date or such lesser period as executive remains eligible under COBRA, unless the termination of executive’s employment occurs within 12 months following a Change in Control, in which case executive will receive the benefits under executive’s Retention Agreement; and (c) and an additional one (1) year of time-based vesting on any unvested options, restricted stock and restricted stock units as of the termination date. In the event that executive’s employment terminates due to death or disability, and subject to execution of a release of claims, executive or his dependents will be eligible to

    9


    Table of Contents

     

    receive the following severance and related post-termination benefits: (i) payment by the Company of Health Benefits for the 18 month period following the termination date or such lesser period as provided under COBRA, and (ii) one hundred percent (100%) of all performance and time-based unvested options, restricted stock and restricted stock units will immediately vest upon executive’s termination date. Additionally, one hundred percent (100%) of all performance and time based options, restricted stock and restricted stock units not already vested, shall become immediately vested upon the occurrence of both (a) a Change in Control, (b) followed by the first to occur of (i) a termination of executive’s employment by the Company or any successor thereto without Cause, (ii) a material diminution in the nature or scope of executive’s duties, responsibilities, authorities, powers or functions that constitutes Good Reason, or (iii) the twelve month anniversary of the occurrence of the Change in Control provided that executive then remains an employee of the Company or its successor (collectively, the “Double-Trigger Change in Control Acceleration”).

     

    Equity Awards

    The equity awards set forth in the table following the Outstanding Equity Awards at 2023 Fiscal Year-End section of this Amendment above are subject to certain conditions on vesting as well as accelerated vesting in part or in full in the event of a Change in Control or for certain awards in the event of Double-Trigger Change in Control Acceleration.

    Retention Agreement

    We have entered into a retention agreement with Mr. Arends that provides that in the event of a Change in Control, he would be entitled to a lump sum payment equal to two times the amount calculated by adding (1) his annual salary at that time plus (2) the greater of (a) any bonus he earned with respect to the prior fiscal year, or (b) his pro rata portion of the aggregate bonus pool under our Incentive Plan for the current year assuming achievement under the Incentive Plan of the maximum performance targets for such year. With respect to Mr. Arends, if within twelve (12) months following a Change in Control: (1) the Company shall terminate his employment with the Company without cause, or (2) he shall voluntarily terminate such employment for Good Reason, the Company shall provide reimbursement of health care premiums for him and his dependents, for a period of eighteen (18) months from the date of his termination, to the extent that he is eligible for and elects continuation coverage under COBRA (provided that such reimbursement shall terminate upon commencement of new employment by an employer that offers health care coverage to its employees). In consideration for the Company’s willingness to enter into an amended and restated employment agreement with Mr. Arends, he relinquished the excise tax gross-up provision which was contained in the retention agreement.

     

    Pay versus Performance

     

    The following table sets forth the compensation information of our principal executive officer (the “PEO”), and the average compensation information of our other named executive officers (“non-PEO NEOs”), both as reported in the Summary Compensation Table and with certain adjustments to reflect the “compensation actually paid” (“CAP”, as calculated in accordance with the SEC rules) to such individuals, and certain measures of the Company’s financial performance, for each of FY 2023, 2022, and 2021.

     

     

     

    PEO (1)

     

    PEO (2)

     

    PEO (3)

    Fiscal Year

     

    Summary Compensation Table Total ($)

     

    Compensation Actually Paid ($)

     

    Summary Compensation Table Total ($)

     

    Compensation Actually Paid ($)

     

    Summary Compensation Table Total ($)

     

    Compensation Actually Paid ($)

    2023

     

    1,460,113

     

    1,193,371

     

    529,876

     

    181,122

     

    515,351

     

    58,763

    2022

     

     

     

     

     

    1,181,049

     

    239,989

     

    889,017

     

    138,523

    2021

     

     

     

     

     

    1,310,271

     

    1,776,741

     

    1,014,009

     

    1,379,728

     

    (1) Amounts reported in these columns reflect (i) the total compensation reported in the Summary Compensation Table for Edwin Miller for FY 2023, and (ii) the CAP for Edwin Miller for FY 2023.

    (2) Amounts reported in these columns reflect (i) the total compensation reported in the Summary Compensation Table for Michael Arends for each of FY 2023, 2022, and 2021, and (ii) the CAP for Michael Arends for each of FY 2023, 2022, and 2021.

    10


    Table of Contents

     

    (3) Amounts reported in these columns reflect (i) the total compensation reported in the Summary Compensation Table for Russell C. Horowitz for each of FY 2023, 2022, and 2021, and (ii) the CAP for Russell C. Horowitz for each of FY 2023, 2022, and 2021.

     

     

     

    Non-PEO (4)

     

     

     

     

    Fiscal Year

     

    Average Summary Compensation Table Total

     

    Average Compensation Actaully Paiod ($)

     

    Value of Initial Fixed $100 investment on December 31, 2020 based on Total Shareholder Return ($)

     

    Net Income ($K)

    2023

     

    489,738

     

    349,351

     

    $69.39

     

    (9,910)

    2022

     

    756,756

     

    381,781

     

    $81.63

     

    (8,245)

    2021

     

    563,201

     

    697,184

     

    $126.53

     

    (4,390)

     

    (4) Amounts reported in the Non-PEO NEOs column reflect (i) the average of the total compensation reported in the Summary Compensation Table for Troy Hartless, Holly Aglio, Ryan Polley, and John Roswech for FY 2023, Ryan Polley and John Roswech for FY 2022, and Ryan Polley, John Roswech, and Leila Kirske for FY 2021, and (ii) the average CAP for Troy Hartless, Holly Aglio, Ryan Polley and John Roswech for FY 2023, Ryan Polley and John Roswech for FY 2022, and Ryan Polley, John Roswech, and Leila Kirske for FY 2021.

     

     

    To calculate the CAP, adjustments were made to the amounts reported in the Summary Compensation Table for the applicable year. The deductions, and additions to, total compensation in the Summary Compensation Table by year that were used to calculated CAP include:

     

    Fiscal Year

     

    Summary Compensation Table Total

     

    Grant Date Value of New Awards

     

    Year End Value of New Awards

     

    Change in Value of Unvested Awards

     

    Change in Value of Vested Awards

     

    Values of Awards Canceled as of Prior FYE

    Total Equity CAP

    Total CAP*

     

     

    (1)

     

    (2)

     

    (3)

     

    (4)

     

    (5)

     

    (6)

    (7)=(3)+(4)+(5)+(6)

    (8)=(1)-(2)+(7)

     

    PEO (a)

    1,460,113

     

    1,073,750

     

    807,008

     

    -

     

    -

     

    -

    807,008

    1,193,371

     

    PEO (b)

    529,876

     

    221,650

     

    162,099

     

    (90,651)

     

    (198,552)

     

    -

    (127,105)

    181,122

    2023

    PEO (c)

    515,351

     

    218,267

     

    145,000

     

    (299,973)

     

    (83,348)

     

    -

    (238,320)

    58,763

     

    Average Non-PEO NEO (d)

    489,738

     

    390,367

     

    373,979

     

    -

     

    -

     

    (124,000)

    249,979

    349,351

     

    PEO (b)

    1,181,049

     

    591,360

     

    515,840

     

    (316,445)

     

    (549,095)

     

    -

    (349,700)

    239,989

    2022

    PEO (c)

    889,017

     

    416,470

     

    346,690

     

    (176,636)

     

    (504,078)

     

    -

    (334,024)

    138,523

     

    Average Non-PEO NEO (d)

    756,756

     

    188,000

     

    124,000

     

    (103,414)

     

    (207,561)

     

    -

    (186,975)

    381,781

     

    PEO (b)

    1,310,271

     

    511,900

     

    550,080

     

    180,020

     

    248,270

     

    -

    978,370

    1,776,741

    2021

    PEO (c)

    1,014,009

     

    378,790

     

    401,670

     

    89,825

     

    253,014

     

    -

    744,509

    1,379,728

     

    Average Non-PEO NEO(d)

    563,201

     

    101,050

     

    109,933

     

    67,782

     

    57,318

     

    -

    235,033

    697,184

     

    (a) Amounts reported in this row reflect the adjustments to the amounts reported in the Summary Compensation Table for Edwin Miller for FY 2023.

    (b) Amounts reported in this row reflect the adjustments to the amounts reported in the Summary Compensation Table for Michael Arends for each of FY 2023, 2022, and 2021.

    (c) Amounts reported in this row reflect the adjustments to the amounts reported in the Summary Compensation Table for Russell C. Horowitz for each of FY 2023, 2022, and 2021.

    (d) Amounts reported in this row reflect the average adjustments to the amounts reported in the Summary Compensation Table for Troy Hartless, Holly Aglio, Ryan Polley, and John Roswech for FY 2023, for Ryan Polley and John Roswech for FY 2022, and for Ryan Polley, John Roswech, and Leila Kirske for FY 2021.

     

    Pay Versus Performance: Graphical Description

     

    The illustrations below provide graphical descriptions of the relationships between the following:

     

    11


    Table of Contents

     

    • The PEO’s CAP and non-PEO NEO’s CAP and the Company’s cumulative total shareholder return (“TSR”); and

     

    • The PEO’s CAP and non-PEO NEO’s CAP and the Company’s net income.

     

    Compensation Actually Paid versus TSR

     

    img70764165_0.jpg 

     

    (a) PEO CAP represents the compensation actually paid for Edwin Miller for FY 2023.

    (b) PEO CAP represents the compensation actually paid for Michael Arends for FY 2021, 2022, and 2023.

    (c) PEO CAP represents the compensation actually paid for Russell C. Horowitz for FY 2021, 2022, and 2023.

     

    12


    Table of Contents

     

    Compensation Actually Paid versus Net Income

     

    img70764165_1.jpg 

     

    (a) PEO CAP represents the compensation actually paid for Edwin Miller for FY 2023.

    (b) PEO CAP represents the compensation actually paid for Michael Arends for FY 2021, 2022, and 2023.

    (c) PEO CAP represents the compensation actually paid for Russell C. Horowitz for FY 2021, 2022, and 2023.

     

    Compensation of Directors

     

    The Compensation Committee is responsible for periodically reviewing and recommending to the Board of Directors the compensation of our independent directors. The following table summarizes compensation earned during 2023 by each of our directors, except Mr. Horowitz, our Chairman, and Mr. Arends, our Vice Chairman, whose compensation is reflected in the table following the Summary Compensation Table section of this Amendment above:

    2023 Director Compensation (1)

     

     Name

    Feed Earned or Paid in Cash ($)

    Stock Awards (2) ($)

    Option Awards (2) ($)

    Total ($)

    Dennis Cline

    30,000

    21,600

    17,000

    68,600

    Donald Cogsville

    30,000

    21,600

    17,000

    68,600

    M. Wayne Wisehart

    30,000

    21,600

    17,000

    68,600

     

    (1)
    Includes only those columns relating to compensation awarded to, earned by, or paid to non-employee directors for their services.
    (2)
    The amounts in the stock awards and option awards columns reflect the aggregate grant date fair value of equity awards granted to directors in 2023 in accordance with ASC Topic 718. These amounts do not reflect whether the director has actually realized or will realize a financial benefit from the awards (such as by vesting in a restricted stock).

    13


    Table of Contents

     

    The aggregate number of equity awards made to our independent directors outstanding as of December 31, 2023 were:

     

     Name

    Stock Awards (#)

    Option Awards (#)

    Total (#)

    Dennis Cline

    22,500

    115,000

    137,500

    Donald Cogsville

    22,500

    115,000

    137,500

    M. Wayne Wisehart

    22,500

    115,000

    137,500

     

    In September 2023, based upon the elections of the individual directors at our 2023 annual meeting of stockholders and in accordance with Marchex’s previously announced director compensation policy: (i) the Company granted (i) 15,000 restricted shares of Class B common stock at a purchase price of $.01 per share; and (ii) 20,000 options at an exercise price of $1.45 per share, the exercise price being the closing price of the Company’s stock price on September 28, 2023, in each case under Marchex’s 2021 Stock Incentive Plan to each of Marchex’s directors as compensation for their annual board service. Fifty percent (50%) of such shares of restricted stock and options shall vest on the first and second annual anniversary of the grant date, respectively, and with vesting in full upon a Change in Control in each case assuming continued service on Marchex’s Board of Directors for such period. In addition, Marchex agreed to pay $7,500 in cash per quarter for each independent directors’ annual director service.

    ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

    To the Company’s knowledge, the following table sets forth information regarding the beneficial ownership of our Class A common stock and Class B common stock as of April 25, 2024 by:

     

    •
    each person (or group of affiliated persons) who is known by us to own beneficially more than 5% of the outstanding shares of our Class A common stock or Class B common stock;
    •
    each of our directors and nominees for director;
    •
    each of our executive officers listed in the “Summary Compensation Table” (“NEOs”); and
    •
    all of our directors, nominees for director and executive officers as a group.

    Percentage of beneficial ownership is based on 4,660,927 shares of our Class A common stock and 39,017,668 shares of our Class B common stock outstanding as of April 25, 2024. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of common stock subject to options or restricted stock units held by that person that are currently exercisable or exercisable or issuable upon vesting within 60 days of April 25, 2024, are deemed outstanding. These shares are not, however, deemed outstanding for the purposes of computing the percentage ownership of any other person. Except as otherwise noted below, the address for each beneficial owner listed below is c/o Marchex, Inc., 1200 5thAve., Suite 1200, Seattle, Washington 98101.

    14


    Table of Contents

     

     

     

    Shares Beneficially Owned

     

    Total Voting Power (1) (%)

     

     

    Class A Common Stock

     

    Class B Common Stock

     

     

    Name and, as appropriate, Address of Beneficial Owner

     

    Shares

    %

     

    Shares

    %

     

     

    5% Security Holders:

     

     

     

     

     

     

     

     

    Edenbrook Capital, LLC (2)

     

    -

    -

     

    14,561,905

    37.3

     

    9.4

    116 Radio Circle

     

     

     

     

     

     

     

     

    Mount Kisco, NY 10549

     

     

     

     

     

     

     

     

    Koller Capital LLC (3)

     

    -

    -

     

    3,865,175

    9.9

     

    2.5

    1343 Main Street, Suite 413

     

     

     

     

     

     

     

     

    Sarasota, FL 34236

     

     

     

     

     

     

     

     

    Named Executive Officers and Directors:

     

     

     

     

     

     

     

     

    Holly Aglio (4)

     

    -

    -

     

    -

    -

     

    -

    Michael Arends (5)

     

    -

    -

     

    1,784,792

    4.6

     

    0.2

    Dennis Cline (6)

     

    -

    -

     

    235,260

    *

     

    *

    Donald Cogsville (7)

     

    -

    -

     

    175,623

    *

     

    *

    Troy Hartless (8)

     

    -

    -

     

    37,500

    *

     

    *

    Russell C. Horowitz (9)

     

    4,660,927

    100%

     

    1,323,606

    3.4

     

    75.8

    Edwin Miller(10)

     

    -

    -

     

    93,750

    *

     

    *

    M. Wayne Wisehart (11)

     

    -

    -

     

    406,145

    *

     

    *

    All directors and executive officers as a group (8 persons) (12)

     

    4,660,927

    100%

     

    4,056,675

    10.4

     

    77.5

    Except as indicated in the footnotes below and except as subject to community property laws where applicable, the persons named in the table above have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them.

     

    * Beneficial ownership or total voting power, as the case may be, representing less than one percent.

    1.
    Percentage of voting power represents voting power with respect to shares of our Class A common stock and Class B common stock, as a single class. Each holder of Class A common stock shall be entitled to 25 votes per share of Class A common stock and each holder of Class B common stock shall be entitled to 1 vote per share of Class B common stock on all matters submitted to a vote of stockholders, except as may otherwise be required by law. The Class A common stock is convertible at any time by the holder into shares of Class B common stock on a share-for-share basis.
    2.
    Based on the most recently available Schedule 13D filed with the SEC on November 13, 2023 by Edenbrook Capital, LLC (“Edenbrook”); Jonathan Brolin (“Brolin”), an individual; and Edenbrook Long Only Value Fund, LP (“Edenbrook Fund”). Edenbrook and Brolin report beneficial ownership and shared voting and dispositive power of 14,561,905 shares of our Class B common stock. Edenbrook Long Only Value Fund, LP reports beneficial ownership of 13,239,567 shares of our Class B common stock.
    3.
    Based on the most recently available Schedule 13G filed with the SEC on February 9, 2024 by Koller Capital LLC (“Koller”); Koller Microcap Opportunities Fund LP (“Koller Microcap”); and Ross Koller (“Ross”). Koller, Koller Microcap, and Ross reported beneficial ownership and shared voting and dispositive power of 3,865,175 shares of our Class B common stock.
    4.
    Ms. Aglio upon joining the Company was granted an option to purchase 300,000 shares of our Class B common stock, which vests over a 4 year period.
    5.
    Includes: (1) 298,250 shares of restricted stock subject to vesting; (2) 344,063 shares of our Class B common stock subject to options that are currently exercisable or exercisable within 60 days of April 25, 2024; (3) 18,100 shares of Class B common stock held in an Individual Retirement Account for the benefit of Mr. Arends; and (4) 6,500 shares of Class B common stock held in an Individual Retirement Account for the benefit of Diana Arends, Mr. Arends’ wife. 1,077,879 shares of such Class B common stock have been pledged as collateral to a third-party lender.

    15


    Table of Contents

     

    6.
    Includes: (1) 22,500 shares of restricted stock subject to vesting; (2) 85,000 shares of our Class B common stock subject to options that are currently exercisable or exercisable within 60 days of April 25, 2024; (3) 28,500 shares of our Class B common stock held by DMC Investments, LLC, a limited liability company of which Mr. Cline is the managing member; and (4) 10,000 shares of our Class B common stock held by the Colburn Cline Trust for the benefit of Colburn Cline, the son of Mr. Cline, for which shares Mr. Cline disclaims beneficial ownership.
    7.
    Includes: (1) 22,500 shares of restricted stock subject to vesting; and (2) 85,000 shares of our Class B common stock subject to options that are currently exercisable or exercisable within 60 days of April 25, 2024.
    8.
    Includes 37,500 shares of our Class B common stock subject to options that are currently exercisable or exercisable within 60 days of April 25, 2024.
    9.
    Includes: (1) 4,660,927 shares of our Class A common stock held by MARRCH Investments, LLC; (2) 215,250 shares of restricted stock subject to vesting; (3) 326,688 shares of our Class B common stock subject to options that are currently exercisable or exercisable within 60 days of April 25, 2024; and (4) 5,000 shares of Class B common stock held in an Individual Retirement Account for the benefit of Mr. Horowitz. Mr. Horowitz is the managing member of MARRCH Investments, LLC and, as such, may be deemed to exercise voting and investment power over the shares held by all of these entities.
    10.
    Includes 93,750 shares of our Class B common stock subject to options that are currently exercisable or exercisable within 60 days of April 25, 2024.
    11.
    Includes 22,500 shares of restricted stock subject to vesting; and (2) 85,000 shares of Class B common stock subject to options that are currently exercisable or exercisable within 60 days of April 25, 2024.
    12.
    Includes an aggregate of: (1) 4,660,927 shares of our Class A common stock; (2) 4,056,675 shares of our Class B common stock which includes 10,000 shares for which beneficial ownership has been disclaimed; and (3) 1,057,000 shares of our Class B common stock subject to options that are currently exercisable or exercisable within 60 days of April 25, 2024.
     

    Equity Compensation Plans

     

    2012 Stock Incentive Plan. Our 2012 Stock Incentive Plan was adopted by our Board of Directors and approved by our stockholders on May 4, 2012 (the “2012 Stock Plan”). No further awards were made under the 2012 Stock Plan after December 31, 2021. The 2012 Stock Plan provided for the granting of shares of Class B common stock to employees, directors, and consultants of Marchex, its affiliates and strategic partners and provided for the following types of grants:

    •
    incentive stock options within the meaning of Section 422 of the Internal Revenue Code, sometimes known as ISOs;
    •
    non-statutory stock options, which are options not intended to qualify as ISOs, sometimes known as non-qualified options;
    •
    right to purchase shares pursuant to restricted stock purchase agreements; and
    •
    restricted stock units.

     

    2021 Stock Incentive Plan. Our 2021 Stock Incentive Plan was adopted by our Board of Directors and approved by our stockholders on October 1, 2021 (the “2021 Stock Plan”). The 2021 Stock Plan provides for the granting of shares of Class B common stock to employees, directors, and consultants of Marchex, its affiliates and strategic partners and provides for the following types of grants:

    •
    incentive stock options within the meaning of Section 422 of the Internal Revenue Code, sometimes known as ISOs;
    •
    non-statutory stock options, which are options not intended to qualify as ISOs, sometimes known as non-qualified options;

    16


    Table of Contents

     

    •
    right to purchase shares pursuant to restricted stock purchase agreements; and
    •
    restricted stock units.

    2014 Employee Stock Purchase Plan. Our 2014 employee stock purchase plan was adopted by our Board of Directors and approved by our stockholders on May 3, 2013 (the “2014 ESPP”). The Company authorized an aggregate of 225,000 shares of Class B common stock for issuance under the plan to participating employees. The 2014 ESPP, which expired on December 31, 2023, provided eligible employees the opportunity to purchase the Company’s Class B common stock at a price equal to 95% of the closing price on the last business day of each purchase period. The 2014 ESPP permitted eligible employees to purchase amounts up to 15% of their compensation in the purchase period, and no employee was permitted to purchase stock worth more than $25,000 in any calendar year, valued as of the first day of each purchase period.

     

    Equity Compensation Plan Information

     

    The following table sets forth certain information regarding our Class B common stock that may be issued upon exercise of options, warrants and other rights under all of our existing equity compensation plans as of December 31, 2023:

     

    Plan Category

    Number of Shares to be issued upon exercise of outstanding options, warrants, and rights (#)(a)

     

    Weighted Average exercise price of outstanding options, warrants, and rights ($)(b)

     

    Number of shares remaining available for future issuance under equity compensation plans (excluding shares reflected in column (a)(#)(c)

    Equity compensation plans approved by security holders:

     

     

     

     

     

    2012 stock incentive plan(1)

    1,839,697

     

    3.21

     

    -

    2014 employee stock purchase plan

    -

     

    -

     

    -

    2021 stock incentive plan(2)

    4,309,812

    (3)

    1.75

    (4)

    1,746,479

    Total

    6,149,509

     

    2.06

    (4)

    1,746,479

    The weighted-average exercise price in column (b) is calculated based on outstanding stock options. It does not take into account shares issuable upon vesting of outstanding restricted stock units, which have no exercise price.

    1.
    After December 31, 2021, no awards were made under the 2012 Stock Plan. Consists of stock options to purchase shares of our Class B common stock.
    2.
    We have reserved 6,056,291 shares of Class B common stock for issuance under our 2021 Stock Plan, which includes an increase of 1,294,725 shares to the authorized number of shares available under the plan, which occurred on January 1, 2023.
    3.
    Consists of stock options to purchase 3,690,062 shares of Class B common stock and restricted stock units representing the right to purchase 619,750 shares of our Class B common stock.
    4.
    Calculated exclusive of outstanding restricted stock units.

    ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

    Procedures for Review and Approval of Related Person Transactions

     

    Our Audit Committee is responsible under its charter for reviewing and approving in advance any proposed related party transactions which would require disclosure under Item 404(a) of Regulation S-K and

    17


    Table of Contents

     

    reporting to the Board of Directors on any approved transactions. The Audit Committee is responsible for ensuring that such relationships are on terms commensurate with those that would be extended to an unrelated third party.

     

    Board Independence

     

    The Board of Directors determined that, other than Mr. Horowitz and Mr. Arends, each of the members of the board is an independent director in accordance with NASDAQ listing standards.

    ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

    The Company’s independent registered public accounting firm is RSM US LLP (“RSM”), Seattle, WA, PCAOB ID: 49.

    On November 11, 2022, the Audit Committee approved the selection of RSM to serve as Marchex’s independent registered public accounting firm. Moss Adams LLP (“Moss Adams”) served as Marchex’s independent registered public accounting firm for the fiscal year ended December 31, 2021 and through November 11, 2022.

    Accounting Fees and Services

     

    During fiscal years 2022 and 2023, Moss Adams and RSM provided professional services in the following categories and amounts:

     

    Fee Category

    2022

     

    2023

     

    Moss Adams ($)

    RSM ($)

     

    RSM ($)

    Audit Fees (1)

    159,995

    204,750

     

    328,790

    Audit-Related Fees (2)

    49,875

    -

     

    -

    Tax Fees (3)

    -

    -

     

    -

    Total All Fees

    209,870

    204,750

     

    328,790

    (1)
    Audit Fees consist of professional services rendered for the audit of Marchex’s fiscal year consolidated financial statements, interim review of the condensed consolidated financial statements included in the quarterly reports, and consent and review of registration statements.
    (2)
    Audit-Related Fees consist of professional services rendered for assurance and related services.
    (3)
    Tax fees consist of fees for professional services for tax return preparation and consultation on matters related to state and local tax considerations and tax credits.

     

    The Audit Committee considered whether the provision of non-audit services was compatible with maintaining the independence of Moss Adams at the time provided and the Audit Committee concluded that it was.

     

    The Audit Committee pre-approved 100% of the 2022 and the 2023 services and fees above pursuant to the pre-approval policy described below.

     

    Policy on Pre-Approval by Audit Committee of Services Performed by Independent Registered Public Accounting Firm

     

    The policy of the Audit Committee is to pre-approve all audit and permissible non-audit services to be performed by the independent registered public accounting firm during the fiscal year. The Audit Committee pre-approves services by authorizing specific projects within the categories outlined above, subject to the budget for each category. The Audit Committee’s charter delegates to its Chairman the authority to address any requests for pre-approval of services between Audit Committee meetings, and the Chairman must report any pre-approval decisions to the Audit Committee at its next scheduled meeting.

    18


    Table of Contents

     

    PART IV

    ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.

    1.
    Exhibits

     

    The exhibits listed in the exhibit index of the Form 10-K and the exhibits listed in the exhibit index of this Amendment are filed with, or incorporated by reference in, this report.

     

     

    EXHIBIT INDEX

     

     

     

    Exhibit Number

     

    Description of Document

    †31.1

    Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    †31.2

    Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    104

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    † Filed herewith.

    19


    Table of Contents

     

    SIGNATURES

    Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Seattle, State of Washington on April 29, 2024.

    MARCHEX, INC.

    By:

    /S/ Holly A. Aglio

     

    Chief Financial Officer

    (Principal Financial Officer and Principal Accounting Officer)

     

    20


    Get the next $MCHX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MCHX

    DatePrice TargetRatingAnalyst
    12/28/2021$4.75 → $4.00Buy
    Roth Capital
    More analyst ratings

    $MCHX
    SEC Filings

    View All

    Marchex Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update

    8-K - MARCHEX INC (0001224133) (Filer)

    1/30/26 4:15:26 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    Marchex Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Submission of Matters to a Vote of Security Holders

    8-K - MARCHEX INC (0001224133) (Filer)

    12/17/25 4:15:25 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-Q filed by Marchex Inc.

    10-Q - MARCHEX INC (0001224133) (Filer)

    11/14/25 4:15:48 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    $MCHX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    At NADA, Marchex to Showcase AI-Powered Conversation Intelligence as a Strategic Growth Lever for Auto Dealers Facing a Challenging 2026 Market

    Marchex AI solutions surface revenue opportunities, helping offset forecast economic factors. Marchex® (NASDAQ:MCHX), which harnesses the power of AI and conversation intelligence to provide actionable insights derived from prescriptive vertical-market data analytics, today announced it will exhibit at the 2026 National Automobile Dealers Association (NADA) Show (booth #7337N). As dealerships face a year currently forecast to bring more limited sales growth and increased pressure on service departments, every customer conversation becomes more crucial for success. With consumers anticipated to keep their vehicles longer, service operations will face higher demand and operational challenge

    1/29/26 9:00:00 AM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    Marchex Announces New AI Search Attribution Capability, Enabling Businesses to Capture LLM-Driven Call Sources and Link Them to Outcomes

    Closing the visibility gap as AI assistants like ChatGPT, Gemini, and Perplexity drive more customer calls. Marchex® (NASDAQ:MCHX), which harnesses the power of AI and conversation intelligence to provide actionable insights derived from prescriptive vertical-market data analytics, today announced a new key enhancement within its Engage Platform: the ability for businesses to accurately attribute and analyze LLM-driven phone calls resulting from consumers receiving brand information directly in an LLM search result, even when those customers never visit the company's website. As AI search assistants such as ChatGPT, Gemini, Perplexity, and Copilot increasingly influence how consumers rese

    12/10/25 9:00:00 AM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    Marchex Announces Third Quarter 2025 Results and Agreement in Principle to Acquire Archenia

    Marchex, Inc. (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the third quarter ended September 30, 2025, as well as an agreement in principle to acquire Archenia, Inc. Q3 2025 Financial Highlights GAAP revenue was $11.5 million for the third quarter of 2025, compared to $12.6 million for the third quarter of 2024. Net loss was $1.0 million for the third quarter of 2025 or $(0.02) per diluted share, compared to a net loss of $0.8 million or $(0.02) per diluted share for the third quarter of 2024. Adjusted earnings before interest, taxes, depreciation,

    11/13/25 4:15:00 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    $MCHX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Vice Chairman Arends Michael A

    4 - MARCHEX INC (0001224133) (Issuer)

    12/17/25 4:15:06 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Wisehart Manuel W

    4 - MARCHEX INC (0001224133) (Issuer)

    12/17/25 4:15:09 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Cline Dennis

    4 - MARCHEX INC (0001224133) (Issuer)

    12/17/25 4:15:07 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    $MCHX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Edenbrook Capital, Llc bought $52,827 worth of Class B common stock (30,962 units at $1.71) and bought $125,002 worth of Class B Common Stock (71,513 units at $1.75) (SEC Form 4)

    4 - MARCHEX INC (0001224133) (Issuer)

    3/27/25 5:42:35 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Miller Edwin A bought $9,982 worth of Class B Common Stock (5,787 units at $1.72), increasing direct ownership by 2% to 336,761 units (SEC Form 4)

    4 - MARCHEX INC (0001224133) (Issuer)

    11/19/24 4:15:03 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Miller Edwin A bought $182,548 worth of Class B Common Stock (105,571 units at $1.73), increasing direct ownership by 47% to 330,974 units (SEC Form 4)

    4 - MARCHEX INC (0001224133) (Issuer)

    11/15/24 4:15:04 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    $MCHX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital reiterated coverage on Marchex with a new price target

    Roth Capital reiterated coverage of Marchex with a rating of Buy and set a new price target of $4.00 from $4.75 previously

    12/28/21 10:26:27 AM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    Roth Capital reiterated coverage on Marchex with a new price target

    Roth Capital reiterated coverage of Marchex with a rating of Buy and set a new price target of $4.75 from $3.50 previously

    2/24/21 4:18:40 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    $MCHX
    Leadership Updates

    Live Leadership Updates

    View All

    Marchex Adds Paul Gallagher as Vice President of Channel Sales to Drive Strategic Growth and Expand Its Channel Presence

    Seasoned executive brings extensive experience building high-performing partner ecosystems and scaling revenue across SaaS and data-driven businesses. Marchex (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive revenue acceleration and operational excellence, today announced the appointment of Paul Gallagher as Vice President of Channel Sales. In this new role, Gallagher will be responsible for executing a high-impact channel strategy that accelerates Marchex's reach and revenue through strategic partnerships and alliances. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250717297160/en/Paul

    7/17/25 11:00:00 AM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    Marchex Partners with Microsoft for AI-Based Solution Offerings in Cloud AI

    Microsoft customers worldwide will soon gain access to Marchex's leading vertical market AI data analytics solutions to drive operational excellence and shape business strategies. Marchex (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced that it has signed an agreement to join the Microsoft Cloud AI Partner Program, including the ability to transact through Microsoft Azure Marketplace, which connects customers to Marchex solutions at scale. This collaboration enables Marchex to unlock sales growth as customers maximize their committed Microsoft cloud investments and expand into new sal

    12/11/24 9:00:00 AM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    Marchex Appoints Edwin Miller as New CEO

    Ryan Polley, Chief Operating Officer, Also Promoted to the Role of President Marchex, Inc. (NASDAQ:MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced that Edwin Miller has joined the company as its CEO. Russell Horowitz, Marchex's Chairman of the Board, will continue in this role and Michael Arends will serve as the company's Vice Chairman. A highly experienced entrepreneur and technology industry executive who has led and managed numerous dynamic organizations, Miller most recently was an operating executive with Gemspring Capital, a private equit

    2/6/23 9:00:00 AM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    $MCHX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Trading: Significant Buy at Marchex Inc. on Jun 5

    On June 5, 2024, Miller Edwin A made a significant insider purchase at Marchex Inc., acquiring $272,000 worth of Class B Common Stock, amounting to 200,000 units at a price of $1.36 per unit. This transaction represented a substantial increase in direct ownership by 1,107%, bringing Edwin A's total holdings to 218,066 units as reported in the SEC Form 4. Examining this purchase in the context of previous insider activities reveals interesting patterns worth noting. Horowitz Russell C was granted 15,000 units of Class B Common Stock on October 2, 2023, resulting in a 2% increase in direct ownership to 991,918 units. Similarly, Wisehart Manuel W was granted 15,000 units on the same date, incr

    6/10/24 1:01:02 AM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    $MCHX
    Financials

    Live finance-specific insights

    View All

    Marchex Announces Third Quarter 2025 Results and Agreement in Principle to Acquire Archenia

    Marchex, Inc. (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the third quarter ended September 30, 2025, as well as an agreement in principle to acquire Archenia, Inc. Q3 2025 Financial Highlights GAAP revenue was $11.5 million for the third quarter of 2025, compared to $12.6 million for the third quarter of 2024. Net loss was $1.0 million for the third quarter of 2025 or $(0.02) per diluted share, compared to a net loss of $0.8 million or $(0.02) per diluted share for the third quarter of 2024. Adjusted earnings before interest, taxes, depreciation,

    11/13/25 4:15:00 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    Marchex to Report Third Quarter 2025 Financial Results on Thursday, November 13, 2025

    Marchex (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced that it will release financial results for the third quarter ended September 30, 2025, on Thursday, November 13, 2025, at approximately 4:20 p.m. ET. At that time, Marchex will post the press release in the Press Center section of its corporate website (https://www.marchex.com/about-us/press/). Following the release, management will hold a conference call at 5:00 p.m. ET on Thursday, November 13, 2025, to discuss the results and outlook for the company. A live webcast will be available on the Investors section of the Marchex websit

    11/6/25 4:15:00 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    Marchex Announces Second Quarter 2025 Results

    Marchex, Inc. (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the second quarter ended June 30, 2025. Q2 2025 Financial Highlights GAAP revenue was $11.7 million for the second quarter of 2025, compared to $12.1 million for the second quarter of 2024. Net income was $0.1 million for the second quarter of 2025 or $0.00 per diluted share, compared to a net loss of $0.8 million or $(0.02) per diluted share for the second quarter of 2024. Adjusted earnings before interest, taxes, depreciation, and amortization ("EBITDA") was a gain of $0.6 million for the

    8/12/25 4:15:00 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    $MCHX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Marchex Inc.

    SC 13G - MARCHEX INC (0001224133) (Subject)

    2/14/24 12:00:04 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Marchex Inc. (Amendment)

    SC 13G/A - MARCHEX INC (0001224133) (Subject)

    2/9/24 12:59:36 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13D/A filed by Marchex Inc. (Amendment)

    SC 13D/A - MARCHEX INC (0001224133) (Subject)

    11/13/23 5:02:02 PM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology